AssetMark’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
AssetMark's CLLS Position: Q3 2023 in Review
AssetMark sold out of Cellectis (CLLS) in Q3 2023, closing a stake of 2,721 shares — an estimated $5.35K sold.
AssetMark first reported a position in CLLS in Q1 2022 and held it in 6 quarters. The position peaked at $5.35K in Q2 2023. 30 funds tracked by Wall St. Rank hold CLLS as of Q3 2023.
- AssetMark reported no remaining Cellectis position as of Q3 2023 after selling out during the quarter.
- AssetMark sold 2,721 Cellectis shares in Q3 2023, an estimated $5.35K.
- AssetMark first reported a position in Cellectis in Q1 2022 and held it in 6 quarters.
- AssetMark's Cellectis position peaked at $5.35K in Q2 2023.
- 30 funds tracked by Wall St. Rank held Cellectis as of Q3 2023.
Based on AssetMark's 13F filing for Q3 2023, filed 27 Oct 2023.